Help
RSS
API
Feed
Maltego
Contact
Domain > hypoxanthine.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2019-11-24
104.27.139.143
(
ClassC
)
2026-02-03
104.21.60.27
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Tue, 03 Feb 2026 02:43:22 GMTContent-Type: text/html; charsetutf-8Transfer-Encoding: chunkedConnection: keep-aliveServer: cloudflareNel: {report_to:cf-nel,success_fraction:0.0,max_age:604800}Set-Cookie: PHPSESSID01e0a2ace2a6f981521f4e15aa5a1ea9; path/Expires: Thu, 19 Nov 1981 08:52:00 GMTPragma: no-cacheCache-control: privateX-Powered-By: ThinkPHPReport-To: {group:cf-nel,max_age:604800,endpoints:{url:https://a.nel.cloudflare.com/report/v4?sRmoapHXvRJslNrLcwKBtbWj08Ud%2F%2BCze52aCu7v5DJ9N5zyOD%2BPzxBupO8j20KLZiQ8sr%2FCVY3Moqt1aTNg%2B1JS%2B5p4jewk8COmTvIjf}}Vary: Accept-Encodingcf-cache-status: DYNAMICCF-RAY: 9c7e948e7b9a5ee6-PDXalt-svc: h3:443; ma86400 !DOCTYPE html>html>head>meta charsetutf-8>meta nameviewport contentwidthdevice-width, initial-scale1.0, minimum-scale1.0, maximum-scale1.0, user-scalableno>title>Online Inhibitor – papers about Inhibitor/title>link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/font-awesome.min.css>link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style.css mediaall />link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style_mobile.css mediascreen and (max-width: 750px) />link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style_pc.css mediascreen and (min-width: 750px) />script typetext/javascript src./tpl/Wap/default/Article_/js/jquery-1.11.1.min.js>/script>script typetext/javascript src./tpl/Wap/default/Article_/js/main.js>/script>!--if lt IE 9> link relstylesheet typetext/css hrefcss/style_pc.css>!endif-->/head>body>!-- header -->header> div classheader> div classtoper center clearfix> div classlogo>a href/index.php?gWap&mArticle&aindex>Online inhibitor/a>/div> div classtlink> ul classclearfix> li>a href/index.php?gWap&mArticle&aindex>i classfa fa-bars>/i>/a>/li> /ul> /div> /div> /div>/header>!-- /header -->!-- content -->div idcontent>section> div idpannel classpannel> p classauthor>a classplus hrefjavascript:closePannel()>i classfa fa-times>/i>/a>/p> p classtiter>Archives/p> ul> li onclicksearch(2026-02)>a href#>2026-02/a>/li>li onclicksearch(2026-01)>a href#>2026-01/a>/li>li onclicksearch(2025-12)>a href#>2025-12/a>/li>li onclicksearch(2025-11)>a href#>2025-11/a>/li>li onclicksearch(2025-10)>a href#>2025-10/a>/li>li onclicksearch(2025-09)>a href#>2025-09/a>/li>li onclicksearch(2025-03)>a href#>2025-03/a>/li>li onclicksearch(2025-02)>a href#>2025-02/a>/li>li onclicksearch(2025-01)>a href#>2025-01/a>/li>li onclicksearch(2024-12)>a href#>2024-12/a>/li>li onclicksearch(2024-11)>a href#>2024-11/a>/li>li onclicksearch(2024-10)>a href#>2024-10/a>/li>li onclicksearch(2024-09)>a href#>2024-09/a>/li>li onclicksearch(2024-08)>a href#>2024-08/a>/li>li onclicksearch(2024-07)>a href#>2024-07/a>/li>li onclicksearch(2024-06)>a href#>2024-06/a>/li>li onclicksearch(2024-05)>a href#>2024-05/a>/li>li onclicksearch(2024-04)>a href#>2024-04/a>/li>li onclicksearch(2024-03)>a href#>2024-03/a>/li>li onclicksearch(2024-02)>a href#>2024-02/a>/li>li onclicksearch(2024-01)>a href#>2024-01/a>/li>li onclicksearch(2023-12)>a href#>2023-12/a>/li>li onclicksearch(2023-11)>a href#>2023-11/a>/li>li onclicksearch(2023-10)>a href#>2023-10/a>/li>li onclicksearch(2023-09)>a href#>2023-09/a>/li>li onclicksearch(2023-08)>a href#>2023-08/a>/li>li onclicksearch(2023-07)>a href#>2023-07/a>/li>li onclicksearch(2023-06)>a href#>2023-06/a>/li>li onclicksearch(2023-05)>a href#>2023-05/a>/li>li onclicksearch(2023-04)>a href#>2023-04/a>/li>li onclicksearch(2023-03)>a href#>2023-03/a>/li>li onclicksearch(2023-02)>a href#>2023-02/a>/li>li onclicksearch(2023-01)>a href#>2023-01/a>/li>li onclicksearch(2022-12)>a href#>2022-12/a>/li>li onclicksearch(2022-11)>a href#>2022-11/a>/li>li onclicksearch(2022-10)>a href#>2022-10/a>/li>li onclicksearch(2022-09)>a href#>2022-09/a>/li>li onclicksearch(2022-08)>a href#>2022-08/a>/li>li onclicksearch(2022-07)>a href#>2022-07/a>/li>li onclicksearch(2022-06)>a href#>2022-06/a>/li>li onclicksearch(2022-05)>a href#>2022-05/a>/li>li onclicksearch(2022-04)>a href#>2022-04/a>/li>li onclicksearch(2022-03)>a href#>2022-03/a>/li>li onclicksearch(2022-02)>a href#>2022-02/a>/li>li onclicksearch(2022-01)>a href#>2022-01/a>/li>li onclicksearch(2021-12)>a href#>2021-12/a>/li>li onclicksearch(2021-11)>a href#>2021-11/a>/li>li onclicksearch(2021-10)>a href#>2021-10/a>/li>li onclicksearch(2021-09)>a href#>2021-09/a>/li>li onclicksearch(2021-08)>a href#>2021-08/a>/li>li onclicksearch(2021-07)>a href#>2021-07/a>/li>li onclicksearch(2021-06)>a href#>2021-06/a>/li>li onclicksearch(2021-05)>a href#>2021-05/a>/li>li onclicksearch(2021-04)>a href#>2021-04/a>/li>li onclicksearch(2021-03)>a href#>2021-03/a>/li>li onclicksearch(2021-02)>a href#>2021-02/a>/li>li onclicksearch(2021-01)>a href#>2021-01/a>/li>li onclicksearch(2020-12)>a href#>2020-12/a>/li>li onclicksearch(2020-11)>a href#>2020-11/a>/li>li onclicksearch(2020-10)>a href#>2020-10/a>/li>li onclicksearch(2020-09)>a href#>2020-09/a>/li>li onclicksearch(2020-08)>a href#>2020-08/a>/li>li onclicksearch(2020-07)>a href#>2020-07/a>/li>li onclicksearch(2020-06)>a href#>2020-06/a>/li>li onclicksearch(2020-05)>a href#>2020-05/a>/li>li onclicksearch(2020-04)>a href#>2020-04/a>/li>li onclicksearch(2020-03)>a href#>2020-03/a>/li>li onclicksearch(2020-02)>a href#>2020-02/a>/li>li onclicksearch(2020-01)>a href#>2020-01/a>/li>li onclicksearch(2019-12)>a href#>2019-12/a>/li>li onclicksearch(2019-11)>a href#>2019-11/a>/li>li onclicksearch(2019-10)>a href#>2019-10/a>/li>li onclicksearch(2019-09)>a href#>2019-09/a>/li>li onclicksearch(2019-08)>a href#>2019-08/a>/li>li onclicksearch(2019-07)>a href#>2019-07/a>/li>li onclicksearch(2019-06)>a href#>2019-06/a>/li>li onclicksearch(2019-05)>a href#>2019-05/a>/li>li onclicksearch(2019-04)>a href#>2019-04/a>/li>li onclicksearch(2018-07)>a href#>2018-07/a>/li> /ul> /div>div classmain> div classblank flist> ul classclearfix> li> a classblock href/index.php?gWap&mArticle&adetail&id16169> h5 classtiter>Solving Lysosomal Enzyme Assay Challenges with CA-074 Me .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-02/p> p classintor> CA-074 Me (SKU A8239) is a cell-permeable, highly selective cathepsin B inhibitor that addresses critical hurdles in apoptosis, necroptosis, and lysosomal enzyme inhibition workflows. This article synthesizes scenario-driven laboratory challenges and demonstrates how CA-074 Me delivers reproducible, data-backed solutions to biomedical researchers. The piece emphasizes evidence from recent literature and validated protocols, providing actionable insights for reliable cell death and viability assays. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16168> h5 classtiter>Solving Lysosomal Protease Assay Challenges with CA-074 Me/h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-02/p> p classintor> This article provides scenario-driven, evidence-based strategies for using CA-074 Me (SKU A8239) to improve lysosomal enzyme inhibition and cathepsin B–related workflows. Drawing on recent literature and real-world laboratory pain points, we highlight how CA-074 Me’s cell-permeable, selective inhibition profile supports robust data in apoptosis, necroptosis, and inflammation research. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16167> h5 classtiter>Verapamil HCl in Translational Models: Apoptosis, Inflamm.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-01/p> p classintor> Explore the advanced applications of Verapamil HCl, a leading L-type calcium channel blocker, in apoptosis induction and inflammation attenuation. This article delivers a unique translational perspective on calcium channel inhibition in myeloma cells and arthritis models, expanding on current research frontiers. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16166> h5 classtiter>Brefeldin A (BFA): ATPase Inhibitor and ER Stress Inducer.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-31/p> p classintor> Brefeldin A (BFA) is a potent ATPase inhibitor used as a vesicle transport inhibitor and ER stress inducer in cellular biology. It blocks protein trafficking from the endoplasmic reticulum (ER) to the Golgi apparatus and is a benchmark tool for studying ER stress pathways and apoptosis induction in cancer cell models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16165> h5 classtiter>Brefeldin A (BFA) as a Vesicle Transport and ER Stress In.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-30/p> p classintor> Brefeldin A (BFA) is a potent ATPase and vesicle transport inhibitor widely used to dissect ER stress and protein trafficking in cell biology. As a small-molecule tool, BFA disrupts ER-to-Golgi protein transport, induces apoptosis in cancer models, and enables reproducible perturbation of secretory pathways. Its precise mechanistic action and defined solubility parameters make BFA (SKU B1400) from APExBIO a robust choice for advanced research applications. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16164> h5 classtiter>CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-30/p> p classintor> CA-074 Me, a potent and cell-permeable cathepsin B inhibitor, is transforming apoptosis and necroptosis assays with its unrivaled selectivity and robust intracellular activity. This methyl ester derivative of CA-074 offers researchers a practical and reproducible solution for dissecting lysosomal enzyme function in inflammation and cell death models. Discover actionable protocols, troubleshooting strategies, and advanced applications leveraging CA-074 Me from APExBIO. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16163> h5 classtiter>Verapamil HCl: Mechanistic Insights and Novel Paradigms i.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-29/p> p classintor> Explore the multifaceted mechanisms of Verapamil HCl, a leading L-type calcium channel blocker, with a focus on apoptosis induction, intracellular drug dynamics, and inflammatory disease models. This article uniquely unpacks underexplored mechanistic pathways and translational research directions. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16162> h5 classtiter>Verapamil HCl (SKU B1867): Data-Driven Solutions in Cell .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-29/p> p classintor> This article delivers scenario-based insights for biomedical researchers using Verapamil HCl (SKU B1867) to address reproducibility, apoptosis, and inflammation modeling challenges. Drawing on recent primary literature and validated protocols, it explains how APExBIOs Verapamil HCl empowers robust cell viability, bone, and myeloma assays while optimizing workflow reliability. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16161> h5 classtiter>Brefeldin A (BFA): Advanced Insights into ER Stress, Apop.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-28/p> p classintor> Discover how Brefeldin A, a potent ATPase and vesicle transport inhibitor, enables cutting-edge research into ER stress, apoptosis induction in cancer, and endothelial injury. This article presents unique mechanistic analysis and translational applications, distinguishing itself from previous reviews. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16160> h5 classtiter>Verapamil HCl: L-Type Calcium Channel Blocker for Apoptos.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-28/p> p classintor> Verapamil HCl is a phenylalkylamine L-type calcium channel blocker widely used in research for modulating calcium signaling, apoptosis, and inflammation. Robust evidence demonstrates its utility in myeloma and arthritis models and its ability to regulate TXNIP-linked bone turnover. This article details molecular mechanisms, experimental parameters, and benchmarks for translational research. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16159> h5 classtiter>Unlocking the Lysosomal Axis: Strategic Cathepsin B Inhib.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-27/p> p classintor> This thought-leadership article explores the mechanistic and translational importance of cathepsin B inhibition in necroptosis, apoptosis, and inflammation research. Integrating recent breakthroughs—such as the central role of MLKL-driven lysosomal membrane permeabilization (LMP) and the cytosolic surge of cathepsins—this piece provides actionable guidance for researchers seeking precision tools like CA-074 Me. Beyond summarizing established product features, it advances the conversation with forward-looking strategies for experimental design, competitive positioning, and translational application. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16158> h5 classtiter>Brefeldin A (BFA): Mechanistic Precision and Strategic Le.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-27/p> p classintor> This thought-leadership article unpacks the nuanced mechanistic actions of Brefeldin A (BFA) as an ATPase and vesicle transport inhibitor, providing translational researchers with actionable insights for dissecting ER stress, protein trafficking, and endothelial dysfunction. Integrating recent findings—including moesin’s role as a biomarker in sepsis—the piece offers a strategic roadmap for leveraging APExBIO’s BFA in advanced disease modeling and therapeutic innovation. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16157> h5 classtiter>CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-26/p> p classintor> CA-074 Me is a potent, cell-permeable cathepsin B inhibitor used for dissecting lysosomal protease functions in apoptosis and necroptosis research. Its high specificity and robust inhibition profile make it a gold standard tool for cathepsin signaling studies in inflammation and regulated cell death models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16156> h5 classtiter>Verapamil HCl: Unlocking Calcium Channel Blockade for Tra.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-26/p> p classintor> This thought-leadership article explores Verapamil HCls expanding role as a phenylalkylamine L-type calcium channel blocker in translational research, spotlighting its mechanistic impact on calcium signaling, apoptosis, inflammation, and, most recently, bone turnover via Txnip modulation. Integrating peer-reviewed evidence, including a novel application in osteoporosis, it provides strategic guidance for researchers seeking to bridge preclinical discovery and clinical innovation. With insights drawn from both foundational and cutting-edge studies, APExBIO’s Verapamil HCl emerges as a versatile, rigorously validated tool for advancing research in myeloma, arthritis, and osteoporosis models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16155> h5 classtiter>CA-074 Me: Selective, Cell-Permeable Cathepsin B Inhibito.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-25/p> p classintor> CA-074 Me is a potent, membrane-permeable cathepsin B inhibitor (IC50 36.3 nM) widely used in lysosomal enzyme research. It provides highly selective inhibition of cathepsin B and partial suppression of cathepsin L under reducing conditions, enabling precise dissection of apoptosis, necroptosis, and inflammation mechanisms. /p> /a> /li> /ul> p classcenter P10> 16159 records 1/1078 page a href/index.php?mArticle&aindex&p2>Next/a> span classcurrent>1/span>a href/index.php?mArticle&aindex&p2>2/a>a href/index.php?mArticle&aindex&p3>3/a>a href/index.php?mArticle&aindex&p4>4/a>a href/index.php?mArticle&aindex&p5>5/a> a href/index.php?mArticle&aindex&p6 >下5页/a> a href/index.php?mArticle&aindex&p1078 >Last page/a>/p> /div>/div>/div>!-- /content -->script> function search(date){ location.href /index.php?gWap&mArticle&aindex&month+date; } function detail(id){ location.href /index.php?gWap&mArticle&adetail&id+id; }/script>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Tue, 03 Feb 2026 02:43:22 GMTContent-Type: text/html; charsetutf-8Transfer-Encoding: chunkedConnection: keep-aliveServer: cloudflareNel: {report_to:cf-nel,success_fraction:0.0,max_age:604800}Set-Cookie: PHPSESSID90f17e151987e48cb478f2364637cece; path/Expires: Thu, 19 Nov 1981 08:52:00 GMTPragma: no-cacheCache-control: privateX-Powered-By: ThinkPHPReport-To: {group:cf-nel,max_age:604800,endpoints:{url:https://a.nel.cloudflare.com/report/v4?smOrC3iZoZp4KBZ6JQdLiCa%2FVMohC6fOPHnUdj2oiDtS664lIMC177DANCtTSce4geyvKoBSqEqgCf1jwS8AzYLjwmCf7pTW5lSrzzdqHPwA%3D}}Vary: Accept-Encodingcf-cache-status: DYNAMICCF-RAY: 9c7e948f4dd05509-PDXalt-svc: h3:443; ma86400 !DOCTYPE html>html>head>meta charsetutf-8>meta nameviewport contentwidthdevice-width, initial-scale1.0, minimum-scale1.0, maximum-scale1.0, user-scalableno>title>Online Inhibitor – papers about Inhibitor/title>link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/font-awesome.min.css>link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style.css mediaall />link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style_mobile.css mediascreen and (max-width: 750px) />link relstylesheet typetext/css href./tpl/Wap/default/Article_/css/style_pc.css mediascreen and (min-width: 750px) />script typetext/javascript src./tpl/Wap/default/Article_/js/jquery-1.11.1.min.js>/script>script typetext/javascript src./tpl/Wap/default/Article_/js/main.js>/script>!--if lt IE 9> link relstylesheet typetext/css hrefcss/style_pc.css>!endif-->/head>body>!-- header -->header> div classheader> div classtoper center clearfix> div classlogo>a href/index.php?gWap&mArticle&aindex>Online inhibitor/a>/div> div classtlink> ul classclearfix> li>a href/index.php?gWap&mArticle&aindex>i classfa fa-bars>/i>/a>/li> /ul> /div> /div> /div>/header>!-- /header -->!-- content -->div idcontent>section> div idpannel classpannel> p classauthor>a classplus hrefjavascript:closePannel()>i classfa fa-times>/i>/a>/p> p classtiter>Archives/p> ul> li onclicksearch(2026-02)>a href#>2026-02/a>/li>li onclicksearch(2026-01)>a href#>2026-01/a>/li>li onclicksearch(2025-12)>a href#>2025-12/a>/li>li onclicksearch(2025-11)>a href#>2025-11/a>/li>li onclicksearch(2025-10)>a href#>2025-10/a>/li>li onclicksearch(2025-09)>a href#>2025-09/a>/li>li onclicksearch(2025-03)>a href#>2025-03/a>/li>li onclicksearch(2025-02)>a href#>2025-02/a>/li>li onclicksearch(2025-01)>a href#>2025-01/a>/li>li onclicksearch(2024-12)>a href#>2024-12/a>/li>li onclicksearch(2024-11)>a href#>2024-11/a>/li>li onclicksearch(2024-10)>a href#>2024-10/a>/li>li onclicksearch(2024-09)>a href#>2024-09/a>/li>li onclicksearch(2024-08)>a href#>2024-08/a>/li>li onclicksearch(2024-07)>a href#>2024-07/a>/li>li onclicksearch(2024-06)>a href#>2024-06/a>/li>li onclicksearch(2024-05)>a href#>2024-05/a>/li>li onclicksearch(2024-04)>a href#>2024-04/a>/li>li onclicksearch(2024-03)>a href#>2024-03/a>/li>li onclicksearch(2024-02)>a href#>2024-02/a>/li>li onclicksearch(2024-01)>a href#>2024-01/a>/li>li onclicksearch(2023-12)>a href#>2023-12/a>/li>li onclicksearch(2023-11)>a href#>2023-11/a>/li>li onclicksearch(2023-10)>a href#>2023-10/a>/li>li onclicksearch(2023-09)>a href#>2023-09/a>/li>li onclicksearch(2023-08)>a href#>2023-08/a>/li>li onclicksearch(2023-07)>a href#>2023-07/a>/li>li onclicksearch(2023-06)>a href#>2023-06/a>/li>li onclicksearch(2023-05)>a href#>2023-05/a>/li>li onclicksearch(2023-04)>a href#>2023-04/a>/li>li onclicksearch(2023-03)>a href#>2023-03/a>/li>li onclicksearch(2023-02)>a href#>2023-02/a>/li>li onclicksearch(2023-01)>a href#>2023-01/a>/li>li onclicksearch(2022-12)>a href#>2022-12/a>/li>li onclicksearch(2022-11)>a href#>2022-11/a>/li>li onclicksearch(2022-10)>a href#>2022-10/a>/li>li onclicksearch(2022-09)>a href#>2022-09/a>/li>li onclicksearch(2022-08)>a href#>2022-08/a>/li>li onclicksearch(2022-07)>a href#>2022-07/a>/li>li onclicksearch(2022-06)>a href#>2022-06/a>/li>li onclicksearch(2022-05)>a href#>2022-05/a>/li>li onclicksearch(2022-04)>a href#>2022-04/a>/li>li onclicksearch(2022-03)>a href#>2022-03/a>/li>li onclicksearch(2022-02)>a href#>2022-02/a>/li>li onclicksearch(2022-01)>a href#>2022-01/a>/li>li onclicksearch(2021-12)>a href#>2021-12/a>/li>li onclicksearch(2021-11)>a href#>2021-11/a>/li>li onclicksearch(2021-10)>a href#>2021-10/a>/li>li onclicksearch(2021-09)>a href#>2021-09/a>/li>li onclicksearch(2021-08)>a href#>2021-08/a>/li>li onclicksearch(2021-07)>a href#>2021-07/a>/li>li onclicksearch(2021-06)>a href#>2021-06/a>/li>li onclicksearch(2021-05)>a href#>2021-05/a>/li>li onclicksearch(2021-04)>a href#>2021-04/a>/li>li onclicksearch(2021-03)>a href#>2021-03/a>/li>li onclicksearch(2021-02)>a href#>2021-02/a>/li>li onclicksearch(2021-01)>a href#>2021-01/a>/li>li onclicksearch(2020-12)>a href#>2020-12/a>/li>li onclicksearch(2020-11)>a href#>2020-11/a>/li>li onclicksearch(2020-10)>a href#>2020-10/a>/li>li onclicksearch(2020-09)>a href#>2020-09/a>/li>li onclicksearch(2020-08)>a href#>2020-08/a>/li>li onclicksearch(2020-07)>a href#>2020-07/a>/li>li onclicksearch(2020-06)>a href#>2020-06/a>/li>li onclicksearch(2020-05)>a href#>2020-05/a>/li>li onclicksearch(2020-04)>a href#>2020-04/a>/li>li onclicksearch(2020-03)>a href#>2020-03/a>/li>li onclicksearch(2020-02)>a href#>2020-02/a>/li>li onclicksearch(2020-01)>a href#>2020-01/a>/li>li onclicksearch(2019-12)>a href#>2019-12/a>/li>li onclicksearch(2019-11)>a href#>2019-11/a>/li>li onclicksearch(2019-10)>a href#>2019-10/a>/li>li onclicksearch(2019-09)>a href#>2019-09/a>/li>li onclicksearch(2019-08)>a href#>2019-08/a>/li>li onclicksearch(2019-07)>a href#>2019-07/a>/li>li onclicksearch(2019-06)>a href#>2019-06/a>/li>li onclicksearch(2019-05)>a href#>2019-05/a>/li>li onclicksearch(2019-04)>a href#>2019-04/a>/li>li onclicksearch(2018-07)>a href#>2018-07/a>/li> /ul> /div>div classmain> div classblank flist> ul classclearfix> li> a classblock href/index.php?gWap&mArticle&adetail&id16169> h5 classtiter>Solving Lysosomal Enzyme Assay Challenges with CA-074 Me .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-02/p> p classintor> CA-074 Me (SKU A8239) is a cell-permeable, highly selective cathepsin B inhibitor that addresses critical hurdles in apoptosis, necroptosis, and lysosomal enzyme inhibition workflows. This article synthesizes scenario-driven laboratory challenges and demonstrates how CA-074 Me delivers reproducible, data-backed solutions to biomedical researchers. The piece emphasizes evidence from recent literature and validated protocols, providing actionable insights for reliable cell death and viability assays. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16168> h5 classtiter>Solving Lysosomal Protease Assay Challenges with CA-074 Me/h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-02/p> p classintor> This article provides scenario-driven, evidence-based strategies for using CA-074 Me (SKU A8239) to improve lysosomal enzyme inhibition and cathepsin B–related workflows. Drawing on recent literature and real-world laboratory pain points, we highlight how CA-074 Me’s cell-permeable, selective inhibition profile supports robust data in apoptosis, necroptosis, and inflammation research. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16167> h5 classtiter>Verapamil HCl in Translational Models: Apoptosis, Inflamm.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-02-01/p> p classintor> Explore the advanced applications of Verapamil HCl, a leading L-type calcium channel blocker, in apoptosis induction and inflammation attenuation. This article delivers a unique translational perspective on calcium channel inhibition in myeloma cells and arthritis models, expanding on current research frontiers. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16166> h5 classtiter>Brefeldin A (BFA): ATPase Inhibitor and ER Stress Inducer.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-31/p> p classintor> Brefeldin A (BFA) is a potent ATPase inhibitor used as a vesicle transport inhibitor and ER stress inducer in cellular biology. It blocks protein trafficking from the endoplasmic reticulum (ER) to the Golgi apparatus and is a benchmark tool for studying ER stress pathways and apoptosis induction in cancer cell models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16165> h5 classtiter>Brefeldin A (BFA) as a Vesicle Transport and ER Stress In.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-30/p> p classintor> Brefeldin A (BFA) is a potent ATPase and vesicle transport inhibitor widely used to dissect ER stress and protein trafficking in cell biology. As a small-molecule tool, BFA disrupts ER-to-Golgi protein transport, induces apoptosis in cancer models, and enables reproducible perturbation of secretory pathways. Its precise mechanistic action and defined solubility parameters make BFA (SKU B1400) from APExBIO a robust choice for advanced research applications. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16164> h5 classtiter>CA-074 Me: Precision Cathepsin B Inhibitor for Lysosomal .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-30/p> p classintor> CA-074 Me, a potent and cell-permeable cathepsin B inhibitor, is transforming apoptosis and necroptosis assays with its unrivaled selectivity and robust intracellular activity. This methyl ester derivative of CA-074 offers researchers a practical and reproducible solution for dissecting lysosomal enzyme function in inflammation and cell death models. Discover actionable protocols, troubleshooting strategies, and advanced applications leveraging CA-074 Me from APExBIO. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16163> h5 classtiter>Verapamil HCl: Mechanistic Insights and Novel Paradigms i.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-29/p> p classintor> Explore the multifaceted mechanisms of Verapamil HCl, a leading L-type calcium channel blocker, with a focus on apoptosis induction, intracellular drug dynamics, and inflammatory disease models. This article uniquely unpacks underexplored mechanistic pathways and translational research directions. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16162> h5 classtiter>Verapamil HCl (SKU B1867): Data-Driven Solutions in Cell .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-29/p> p classintor> This article delivers scenario-based insights for biomedical researchers using Verapamil HCl (SKU B1867) to address reproducibility, apoptosis, and inflammation modeling challenges. Drawing on recent primary literature and validated protocols, it explains how APExBIOs Verapamil HCl empowers robust cell viability, bone, and myeloma assays while optimizing workflow reliability. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16161> h5 classtiter>Brefeldin A (BFA): Advanced Insights into ER Stress, Apop.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-28/p> p classintor> Discover how Brefeldin A, a potent ATPase and vesicle transport inhibitor, enables cutting-edge research into ER stress, apoptosis induction in cancer, and endothelial injury. This article presents unique mechanistic analysis and translational applications, distinguishing itself from previous reviews. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16160> h5 classtiter>Verapamil HCl: L-Type Calcium Channel Blocker for Apoptos.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-28/p> p classintor> Verapamil HCl is a phenylalkylamine L-type calcium channel blocker widely used in research for modulating calcium signaling, apoptosis, and inflammation. Robust evidence demonstrates its utility in myeloma and arthritis models and its ability to regulate TXNIP-linked bone turnover. This article details molecular mechanisms, experimental parameters, and benchmarks for translational research. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16159> h5 classtiter>Unlocking the Lysosomal Axis: Strategic Cathepsin B Inhib.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-27/p> p classintor> This thought-leadership article explores the mechanistic and translational importance of cathepsin B inhibition in necroptosis, apoptosis, and inflammation research. Integrating recent breakthroughs—such as the central role of MLKL-driven lysosomal membrane permeabilization (LMP) and the cytosolic surge of cathepsins—this piece provides actionable guidance for researchers seeking precision tools like CA-074 Me. Beyond summarizing established product features, it advances the conversation with forward-looking strategies for experimental design, competitive positioning, and translational application. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16158> h5 classtiter>Brefeldin A (BFA): Mechanistic Precision and Strategic Le.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-27/p> p classintor> This thought-leadership article unpacks the nuanced mechanistic actions of Brefeldin A (BFA) as an ATPase and vesicle transport inhibitor, providing translational researchers with actionable insights for dissecting ER stress, protein trafficking, and endothelial dysfunction. Integrating recent findings—including moesin’s role as a biomarker in sepsis—the piece offers a strategic roadmap for leveraging APExBIO’s BFA in advanced disease modeling and therapeutic innovation. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16157> h5 classtiter>CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal .../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-26/p> p classintor> CA-074 Me is a potent, cell-permeable cathepsin B inhibitor used for dissecting lysosomal protease functions in apoptosis and necroptosis research. Its high specificity and robust inhibition profile make it a gold standard tool for cathepsin signaling studies in inflammation and regulated cell death models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16156> h5 classtiter>Verapamil HCl: Unlocking Calcium Channel Blockade for Tra.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-26/p> p classintor> This thought-leadership article explores Verapamil HCls expanding role as a phenylalkylamine L-type calcium channel blocker in translational research, spotlighting its mechanistic impact on calcium signaling, apoptosis, inflammation, and, most recently, bone turnover via Txnip modulation. Integrating peer-reviewed evidence, including a novel application in osteoporosis, it provides strategic guidance for researchers seeking to bridge preclinical discovery and clinical innovation. With insights drawn from both foundational and cutting-edge studies, APExBIO’s Verapamil HCl emerges as a versatile, rigorously validated tool for advancing research in myeloma, arthritis, and osteoporosis models. /p> /a> /li>li> a classblock href/index.php?gWap&mArticle&adetail&id16155> h5 classtiter>CA-074 Me: Selective, Cell-Permeable Cathepsin B Inhibito.../h5> p classtimer>i classfa fa-calendar-minus-o>/i> 2026-01-25/p> p classintor> CA-074 Me is a potent, membrane-permeable cathepsin B inhibitor (IC50 36.3 nM) widely used in lysosomal enzyme research. It provides highly selective inhibition of cathepsin B and partial suppression of cathepsin L under reducing conditions, enabling precise dissection of apoptosis, necroptosis, and inflammation mechanisms. /p> /a> /li> /ul> p classcenter P10> 16159 records 1/1078 page a href/index.php?mArticle&aindex&p2>Next/a> span classcurrent>1/span>a href/index.php?mArticle&aindex&p2>2/a>a href/index.php?mArticle&aindex&p3>3/a>a href/index.php?mArticle&aindex&p4>4/a>a href/index.php?mArticle&aindex&p5>5/a> a href/index.php?mArticle&aindex&p6 >下5页/a> a href/index.php?mArticle&aindex&p1078 >Last page/a>/p> /div>/div>/div>!-- /content -->script> function search(date){ location.href /index.php?gWap&mArticle&aindex&month+date; } function detail(id){ location.href /index.php?gWap&mArticle&adetail&id+id; }/script>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]